{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:28:46Z","timestamp":1776320926325,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jaci.2021.11.029","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T10:19:27Z","timestamp":1643537967000},"page":"75-81.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of the overuse of short-acting \u03b22-agonists on the risk of sepsis and septic shock"],"prefix":"10.1016","volume":"150","author":[{"given":"Chih-Cheng","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Chien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.11.029_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2021.11.029_bib2","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2214-109X(17)30007-4","article-title":"Causes and outcomes of sepsis in southeast Asia: a multinational multicentre cross-sectional study","volume":"5","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jaci.2021.11.029_bib3","article-title":"Epidemiology of sepsis in Taiwan","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.11.029_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.11.029_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jaci.2021.11.029_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis","volume":"23","author":"Vincent","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jaci.2021.11.029_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0885066616689548","article-title":"Misdirected sympathy: the role of sympatholysis in sepsis and septic shock","volume":"33","author":"Ferreira","year":"2018","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jaci.2021.11.029_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fphar.2015.00171","article-title":"Adrenergic regulation of innate immunity: a review","volume":"6","author":"Scanzano","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaci.2021.11.029_bib11","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2021.11.029_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40261-015-0325-3","article-title":"Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial","volume":"35","author":"Wang","year":"2015","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jaci.2021.11.029_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196174","article-title":"Influence of beta-blocker therapy on the risk of infections and death in patients at high risk for stroke induced immunodepression","volume":"13","author":"Maier","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.11.029_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13054-019-2562-y","article-title":"The association between premorbid beta blocker exposure and mortality in sepsis\u2014a systematic review","volume":"23","author":"Tan","year":"2019","journal-title":"Crit Care"},{"key":"10.1016\/j.jaci.2021.11.029_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-028995","article-title":"Understanding reliever overuse in patients purchasing over-the-counter short-acting beta(2) agonists: an Australian community pharmacy-based survey","volume":"9","author":"Azzi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaci.2021.11.029_bib17","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12325-020-01233-0","article-title":"SABINA: an overview of short-acting \u03b2(2)-agonist use in asthma in European countries","volume":"37","author":"Janson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaci.2021.11.029_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting \u03b2(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.11.029_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4187\/respcare.06051","article-title":"Clinical pharmacology of bronchodilator medications","volume":"63","author":"Williams","year":"2018","journal-title":"Respir Care"},{"key":"10.1016\/j.jaci.2021.11.029_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41533-021-00231-1","article-title":"The prevalence and outcome of short-acting \u03b22-agonists overuse in asthma patients in Taiwan","volume":"31","author":"Wang","year":"2021","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.anai.2012.08.014","article-title":"Short-acting \u03b2-agonist use and its ability to predict future asthma-related outcomes","volume":"109","author":"Stanford","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.11.029_bib22","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jaip.2020.03.013","article-title":"Usage patterns of short-acting \u03b2(2)-agonists and inhaled corticosteroids in asthma: a targeted literature review","volume":"8","author":"Amin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.11.029_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41533-020-0164-4","article-title":"Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan","volume":"30","author":"Chang","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib25","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/CCM.0000000000003475","article-title":"Risk of sepsis and mortality among patients with chronic obstructive pulmonary disease treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"47","author":"Lai","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1097\/CCM.0000000000002550","article-title":"Preadmission use of calcium channel blocking agents is associated with improved outcomes in patients with sepsis: a population-based propensity score-matched cohort study","volume":"45","author":"Lee","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jaci.2021.11.029_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1378\/chest.09-2205","article-title":"Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006","volume":"138","author":"Shen","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2021.11.029_bib28","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.jaip.2020.12.035","article-title":"GINA 2020: potential impacts, opportunities and challenges for primary care","volume":"9","author":"Kaplan","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.11.029_bib29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/02770903.2020.1777563","article-title":"Position statement: asthma in Latin America. Is short-acting beta-2 agonist helping or compromising asthma management?","volume":"58","author":"Nannini","year":"2020","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2021.11.029_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12931-019-1159-y","article-title":"It is time to change the way we manage mild asthma: an update in GINA 2019","volume":"20","author":"Muneswarao","year":"2019","journal-title":"Respir Res"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922001282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674922001282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:36:21Z","timestamp":1758792981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674922001282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0091674922001282"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.029","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of the overuse of short-acting \u03b22-agonists on the risk of sepsis and septic shock","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}